As of Friday, December 26, Sol-Gel Technologies Ltd.’s SLGL share price has dipped by 5.05%, which has investors questioning if this is right time to buy.

Sol-Gel Technologies reports increased Q1 revenue and expenses, with a net loss of $8.8 million compared to $6.3 million in 2024. Sol-Gel Technologies, Ltd., a clinical-stage dermatology company, ...

Sol-Gel Technologies secures $16 million for clinical trials, advancing SGT-610 for Gorlin syndrome and extending cash runway to 2027. Sol-Gel Technologies, Ltd. has announced a product purchase ...

Just because a business does not make any money, does not mean that the stock will go down. For example, Sol-Gel Technologies (NASDAQ:SLGL) shareholders have done very well over the last year, with ...